SPDR S&P Pharmaceuticals ETFXPH
XPH
$43.33
0.98%
Market Cap: $182M
0
Funds holding %
of 6,686 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
1.05% more ownership
Funds ownership: 55.29% [Q1] → 56.34% (+1.05%) [Q2]
1% less funds holding
Funds holding: 71 [Q1] → 70 (-1) [Q2]
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
14% less capital invested
Capital invested by funds: $123M [Q1] → $105M (-$17.7M) [Q2]
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
44% less call options, than puts
Call options by funds: $839K | Put options by funds: $1.51M
Research analyst outlook
We haven’t received any recent analyst ratings for XPH.